| Lung Diagnosis Group | Year | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | |
| Total | 874 | 1,029 | 1,254 | 1,421 | 1,482 | 1,653 | 2,057 | 1,788 | 1,205 | 927 |
| Group A: Obstructive Lung Disease | 332 | 415 | 511 | 541 | 586 | 624 | 757 | 642 | 423 | 349 |
| Group B: Pulmonary Vascular Disease | 204 | 229 | 251 | 311 | 320 | 376 | 402 | 344 | 207 | 147 |
| Group C: Cystic Fibrosis or Immunodef. Disorders | 107 | 122 | 154 | 187 | 185 | 197 | 295 | 259 | 179 | 142 |
| Group D: Restrictive Lung Disease | 174 | 215 | 284 | 338 | 357 | 436 | 581 | 506 | 362 | 250 |
| Group E: Age Less Than 12 | 29 | 27 | 37 | 32 | 25 | 16 | 19 | 31 | 29 | 34 |
| Other Diagnosis | 28 | 21 | 17 | 12 | 9 | 4 | 3 | 6 | 5 | 5 |
| Total (%) | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Group A: Obstructive Lung Disease | 38.0% | 40.3% | 40.7% | 38.1% | 39.5% | 37.7% | 36.8% | 35.9% | 35.1% | 37.6% |
| Group B: Pulmonary Vascular Disease | 23.3% | 22.3% | 20.0% | 21.9% | 21.6% | 22.7% | 19.5% | 19.2% | 17.2% | 15.9% |
| Group C: Cystic Fibrosis or Immunodef. Disorders | 12.2% | 11.9% | 12.3% | 13.2% | 12.5% | 11.9% | 14.3% | 14.5% | 14.9% | 15.3% |
| Group D: Restrictive Lung Disease | 19.9% | 20.9% | 22.6% | 23.8% | 24.1% | 26.4% | 28.2% | 28.3% | 30.0% | 27.0% |
| Group E: Age Less Than 12 | 3.3% | 2.6% | 3.0% | 2.3% | 1.7% | 1.0% | 0.9% | 1.7% | 2.4% | 3.7% |
| Other Diagnosis | 3.2% | 2.0% | 1.4% | 0.8% | 0.6% | 0.2% | 0.1% | 0.3% | 0.4% | 0.5% |